FFO
EBS icon

Fortitude Family Office’s Emergent Biosolutions EBS Stock Holding History

Fortitude Family Office’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$6.55K Buy
+993
New +$6.52K ﹤0.01% 1430
2026
Q2 		– Sell
-108
Closed -$896 – 2299
2026
Q1 		$896 Buy
+108
New +$1.12K ﹤0.01% 1532
2025
Q3 		– Sell
-74
Closed -$472 – 2027
2025
Q2 		$472 Buy
+74
New +$423 ﹤0.01% 1841

Other funds holding EBS

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
MFT
Moisand Fitzgerald Tamayo Orlando, Florida $995M AUM 13.19% 1-Year Est. Return
TCM
Triumph Capital Management Denver, Colorado $573M AUM 15.32% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
MassMutual Private Wealth & Trust
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

Fortitude Family Office's EBS Position: Q3 2026 in Review

Fortitude Family Office opened a new position in Emergent Biosolutions (EBS) in Q3 2026: 993 shares worth $6.55K. The stake represents ﹤0.01% of the portfolio and ranks #1430 among its holdings. This is a return to the name: Fortitude Family Office previously reported a position in EBS as recently as Q1 2026.

Fortitude Family Office first reported a position in EBS in Q2 2025 and has held it in 3 quarters since. 12 funds tracked by Wall St. Rank hold EBS as of Q3 2026.

  • Fortitude Family Office held 993 shares of Emergent Biosolutions worth $6.55K as of Q3 2026.
  • Emergent Biosolutions was a new Fortitude Family Office position in Q3 2026.
  • Emergent Biosolutions made up ﹤0.01% of Fortitude Family Office's portfolio in Q3 2026, its #1430 holding.
  • Fortitude Family Office first reported a position in Emergent Biosolutions in Q2 2025 and has held it in 3 quarters since.
  • 12 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2026.

Based on Fortitude Family Office's 13F filing for Q3 2026, filed 14 Oct 2026.